Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Chiesi Group’s Trimbow wins European licence

European Commission approves the COPD treatment

- PMLiVE

Two new starters boost Wave’s senior team

Sadaf Kazi and Dr Florentia Loizou join the group

- PMLiVE

Medmeme bolsters sales team

Appoints Jeff Sager as senior vice president

- PMLiVE

Most of the EU would like to host the EMA

Nineteen member states will compete to host the agency when it leaves the UK

- PMLiVE

Xtandi slowdown weighs on Pfizer, but CEO won’t move on M&A

Investors call on the pharma giant to consider a large merger or acquisition deal

AstraZeneca AZ

Clock starts ticking on FDA review of AZ’s acalabrutinib

If approved, the BTK inhibitor could achieve annual peak sales of $5bn

- PMLiVE

Truthful consumerism

Amid all the change and uncertainty of this moment,  a set of core truths about our shared future is as relevant as ever

- PMLiVE

Kite files first CAR-T candidate in Europe

But will need to play catch up in the US, where Novartis has a slight lead

- PMLiVE

BMS and Clovis join forces in PARP combo race

Duo will combine Opdivo and Rubraca in phase II and III trials to treat a variety of tumours

- PMLiVE

BMS and Clovis join forces in PARP combo race

Duo will combine Opdivo and Rubraca in phase II and III trials to treat a variety of tumours

- PMLiVE

Aids related deaths almost halved since 2005, says UNAIDS

And 53% of people living with HIV now have access to treatment

- PMLiVE

It’s time to measure outcomes

Lucid launch their new metrics platform

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links